Ingevity(NGVT)

Search documents
Ingevity(NGVT) - 2021 Q3 - Quarterly Report
2021-10-28 20:36
☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 _______________________________________________________________________ FORM 10-Q _______________________________________________________________________ For the quarterly period ended September 30, 2021 (State or other jurisdiction of incorporation or organization) (I.R.S. Employer Identification No.) 4920 O'Hear Avenue Suite 400 North Charleston ...
Ingevity (NGVT) Presents At Industrial Virtual Conference - Slideshow
2021-08-09 15:34
Jefferies Industrials Conference Mary Hall, Chief Financial Officer Bill Hamilton, Treasurer and Investor Relations August 4, 2021 PURIFY I PROTECT I ENHANCE Disclaimer: This presentation contains "forward-looking statements" within the meaning of the Securities Exchange Act of 1934, as amended, and the Private Securities Litigation Reform Act of 1995. Such statements generally include the words "will," "plans," "intends," "targets," "expects," "outlook," or similar expressions. Forward-looking statements m ...
Ingevity(NGVT) - 2021 Q2 - Earnings Call Transcript
2021-07-31 05:50
Ingevity Corporation (NYSE:NGVT) Q2 2021 Earnings Conference Call July 29, 2021 10:00 AM ET Company Participants Bill Hamilton ??? Treasurer and Vice President of Investor Relations John Fortson ??? President and Chief Executive Officer Ed Woodcock ??? President of Performance Materials Mike Smith ??? President of Performance Chemicals Mary Hall ??? Chief Financial Officer Conference Call Participants John McNulty ??? BMO Capital Markets Mike Sison ??? Wells Fargo Mark Zhang ??? Oppenheimer John Tanwanteng ...
Ingevity(NGVT) - 2021 Q2 - Earnings Call Presentation
2021-07-30 15:57
ingevity. Second Quarter 2021 Earnings Presentation July 29, 2021 PURIFY I PROTECT I ENHANCE Disclaimer: This presentation contains "forward-looking statements" within the meaning of the Securities Exchange Act of 1934, as amended, and the Private Securities Litigation Reform Act of 1995. Such statements generally include the words "will," "plans," "intends," "targets," "expects," "outlook," or similar expressions. Forward-looking statements may include, without limitation, expected financial positions, res ...
Ingevity(NGVT) - 2021 Q2 - Quarterly Report
2021-07-29 20:17
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 _______________________________________________________________________ FORM 10-Q _______________________________________________________________________ ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended June 30, 2021 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Commission File Number: 001-37586 _______________________ ...
Ingevity(NGVT) - 2021 Q1 - Earnings Call Transcript
2021-05-01 19:54
Ingevity Corporation (NYSE:NGVT) Q1 2021 Earnings Conference Call April 29, 2021 10:00 AM ET Company Participants Bill Hamilton - Treasurer and Head of Investor Relations John Fortson - President and CEO Mike Smith - President of Performance Chemicals Ed Woodcock - President of Performance Materials Erik Ripple - Chief Growth and Innovation Officer Mary Hall - CFO Conference Call Participants John McNulty - BMO Capital Markets Jon Tanwanteng - CJS Securities Daniel Rizzo - Jefferies Ian Zaffino - Oppenheime ...
Ingevity(NGVT) - 2021 Q1 - Earnings Call Presentation
2021-04-30 23:27
ingevity. First Quarter 2021 Earnings Presentation April 29, 2021 PURIFY I PROTECT I ENHANCE Disclaimer: This presentation contains "forward-looking statements" within the meaning of the Securities Exchange Act of 1934, as amended, and the Private Securities Litigation Reform Act of 1995. Such statements generally include the words "will," "plans," "intends," "targets," "expects," "outlook," or similar expressions. Forward-looking statements may include, without limitation, expected financial positions, res ...
Ingevity(NGVT) - 2021 Q1 - Quarterly Report
2021-04-29 20:18
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 _______________________________________________________________________ FORM 10-Q _______________________________________________________________________ ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended March 31, 2021 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Commission File Number: 001-37586 ______________________ ...
Ingevity(NGVT) - 2020 Q4 - Annual Report
2021-02-19 21:16
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 _______________________________________________________________________ FORM 10-K ______________________________________________________________________________________________________ ☒ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2020 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Commission File Number 001-375 ...
Ingevity(NGVT) - 2020 Q4 - Earnings Call Transcript
2021-02-12 01:22
Ingevity Corporation (NYSE:NGVT) Q4 2020 Earnings Conference Call February 11, 2021 10:00 AM ET Company Participants Jack Maurer - SVP of Public Affairs & IR John Fortson - President, CEO, Interim CFO Mike Smith - President of Performance Chemicals Ed Woodcock - President of Performance Materials Bill Hamilton - Vice President of Financial Planning and Analysis and Treasury Erik Ripple - Chief Growth and Innovation Officer Conference Call Participants John McNulty - BMO Capital Markets Ian Zaffino - Oppenhe ...